Achyut Healthcare (BOM:543499) Marketable Securities: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543499 Achyut Healthcare Ltd BOM:543499
76 GF Score
Price ₹6.94
GF Value ₹8.31
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Achyut Healthcare Marketable Securities?

Achyut Healthcare BOM:543499 +1.91% 76 Marketable Securities is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:543499 with a GF Score™ of 76/100 and a GF Value™ of ₹8.31 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Achyut Healthcare's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Achyut Healthcare's annual Marketable Securities declined from Mar. 2024 (₹142.6 Mil) to Mar. 2025 (₹58.7 Mil) and declined from Mar. 2025 (₹58.7 Mil) to Mar. 2026 (₹0.3 Mil).

Achyut Healthcare  (BOM:543499) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Achyut Healthcare Marketable Securities Related Terms

Achyut Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Achyut Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Achyut Healthcare Marketable Securities Chart

Achyut Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 84.57 142.59 58.73 0.35

Achyut Healthcare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.35 0.00
BOM:543499
76GF Score
Achyut Healthcare Ltd BOM:543499
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Achyut Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0.0 Mil mean?
Achyut Healthcare (BOM:543499) has a Marketable Securities of ₹0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Achyut Healthcare and its competitors.
Is Achyut Healthcare's Marketable Securities too high?
Achyut Healthcare's current Marketable Securities is ₹0.0 Mil. Overall, Achyut Healthcare has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Achyut Healthcare's Marketable Securities compare to competitors?
Achyut Healthcare's Marketable Securities of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Achyut Healthcare and its competitors. Achyut Healthcare's current Marketable Securities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Achyut Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Achyut Healthcare (BOM:543499) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹8.31, compared to a current price of ₹6.94 — trading 16.5% below its estimated fair value. The current Marketable Securities is ₹0.0 Mil. Achyut Healthcare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Achyut Healthcare (BOM:543499), the current Marketable Securities is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Achyut Healthcare (BOM:543499) Overvalued in 2026?

Based on GuruFocus' analysis, Achyut Healthcare stock appears to be undervalued. The current stock price of ₹6.94 is trading 16.5% below its estimated GF Value™ of ₹8.31. GuruFocus considers Achyut Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:543499:

  • Marketable Securities: ₹0.0 Mil
  • GF Value™: ₹8.31 vs. price of ₹6.94 (16.5% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the BOM:543499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Achyut Healthcare Business Description

Address BRTS Bus Stand, Iscon - Ambali Road, 610 Colonade, Behind Iscon Temple, Opposite Iscon, Ahmedabad, GJ, IND, 380058
Achyut Healthcare Ltd is engaged in the manufacturing and trading of Pharmaceutical formulations in the forms of Tablets, Capsules, Oral liquids, and Injectables. The company has business operations in both domestic and international markets. It generates the majority of its revenue from domestic markets.
76GF Score

Get the complete analysis for BOM:543499

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6.94
Price
₹8.31
GF Value